✦ LIBER ✦

Parkinson's disease mortality among male anesthesiologists and internists

✍ Scribed by Chava Peretz; Bruce H. Alexander; Sonia I. Nagahama; Karen B. Domino; Harvey Checkoway

Book ID: 102506911
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 65 KB
Volume: 20
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.20606

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Clusters of Parkinson's disease (PD) among healthcare professionals have been interpreted as evidence of an infectious etiology. Anesthetic gases have also been associated with parkinsonism symptoms and PD among patients undergoing general anesthesia. We investigated PD mortality among large cohorts of male U.S. anesthesiologists (n = 33,040) and internal medicine physicians (n = 33,044). PD mortality for any mention on a death certificate was lower than rates in U.S. men during 1979–1995 for both groups, although anesthesiologists had a significantly elevated risk for PD as underlying cause of death for 10‐year follow‐up. Direct comparisons of mortality between the two cohorts indicated excess PD mortality in anesthesiologists for >10‐year follow‐up for any mention and for underlying cause of death. These findings lend some support to the hypothesis that infectious agents or anesthetic gases may be associated etiologically with PD. © 2005 Movement Disorder Society

📜 SIMILAR VOLUMES

Selegiline and mortality in Parkinson's

Selegiline and mortality in Parkinson's disease

✍ Dr. C. W. Olanow; S. Fahn; J. W. Langston; J. Godbold 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 489 KB 👁 2 views

## Do Other Studies Show Increased Mortality Due to Selegiline? Other than the UK study, no clinical trial to date has shown an increase in mortality in association with the use of selegiline. In the Sindepar study, a cohort of I01 untreated P D patients participated in a 14-month prospective, ran

Mortality in Parkinson's disease

✍ Kurt A. Jellinger 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB

Mortality in Parkinson’s disease

✍ Amos D. Korczyn 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 431 KB

Selegiline and mortality in Parkinson's

Selegiline and mortality in Parkinson's disease: Another view

✍ A. J. Lees; J. Head; Y. Ben Shlomo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB 👁 2 views

Mortality and cancer incidence in patien

Mortality and cancer incidence in patients with Parkinson's disease

✍ Yuko Minami; Reiko Yamamoto; Mitsuaki Nishikouri; Akira Fukao; Shigeru Hisamichi 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 116 KB

Smokeless tobacco use and the risk of Pa

Smokeless tobacco use and the risk of Parkinson's disease mortality

✍ Eilis J. O'Reilly; Marji L. McCullough; Ann Chao; S. Jane Henley; Eugenia E. Cal 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 1 views

## Abstract We examined the association between smokeless tobacco use and Parkinson's disease (PD) mortality as assessed by death certificate in a prospective cohort of 95,981 never‐smoking men. In this cohort, smokeless tobacco use is inversely associated with PD mortality, with an age‐adjusted ri